Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Journal articles
  4. Thioredoxin reductase, an emerging target for anticancer metallodrugs
 
research article

Thioredoxin reductase, an emerging target for anticancer metallodrugs

Gabbiani, C.
•
Mastrobuoni, G.
•
Sorrentino, S.
Show more
2011
Med.Chem.Comm

Enzyme inhibition by cytotoxic gold(III) compounds studied with combined mass spectrometry and biochemical assays

  • Details
  • Metrics
Type
research article
DOI
10.1039/c0md00181c
Web of Science ID

WOS:000286965900006

Author(s)
Gabbiani, C.
Mastrobuoni, G.
Sorrentino, S.
Dani, B.
Rigobello, M. P.
Bindoli, A.
Cinellu, M. A.
Pieraccini, G.
Messori, L.
Casini, A.  
Date Issued

2011

Published in
Med.Chem.Comm
Volume

2

Issue

1

Start page

50

End page

54

Subjects

Solution Chemistry

•

Glutathione-Reductase

•

Molecular-Mechanism

•

Antitumor Agents

•

Cancer-Therapy

•

Gold Compounds

•

Serum-Albumin

•

Complexes

•

Ligands

•

Binding

Editorial or Peer reviewed

REVIEWED

Written at

EPFL

EPFL units
LCOM  
Available on Infoscience
December 22, 2010
Use this identifier to reference this record
https://infoscience.epfl.ch/handle/20.500.14299/62456
Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés